Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Collegium antropologicum
Zdravko PerkoSnjezana Tomić
Journal of Clinical Ultrasound : JCU
Servet KahveciErtugrul Mavili
Acta Paediatrica
J F BruinenbergJ Tolboom
The Kaohsiung Journal of Medical Sciences
Chin-Fan ChenJaw-Yuan Wang
Journal of Pediatric Surgery
C A AngelA P Kumar